← Evidence map

ArticleHistopathology2026

Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition.

Igor Odintsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition. | OpenQuestion